| 1 |
Atorvastatin FDA Label
|
| 2 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 3 |
FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 205945.
|
| 4 |
ClinicalTrials.gov (NCT04380402) Atorvastatin in COVID-19. U.S. National Institutes of Health.
|
| 5 |
Clinical pipeline report, company report or official report of Merck.
|
| 6 |
ClinicalTrials.gov (NCT00627575) AED/Statin Interaction Study
|
| 7 |
ClinicalTrials.gov (NCT00701883) Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol. U. S. National Institute of Health. 2008.
|
| 8 |
ClinicalTrials.gov (NCT01660191) A Study Comparing CoQ10 Levels While Taking 3 Different Statins. U.S. National Institutes of Health.
|
| 9 |
ClinicalTrials.gov (NCT01299597) A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.
|
| 10 |
ClinicalTrials.gov (NCT01617772) Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
|
| 11 |
ClinicalTrials.gov (NCT00490698) Zoledronate With Atorvastatin in Renal Cell Carcinoma
|
| 12 |
ClinicalTrials.gov (NCT00300469) Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
|
| 13 |
ClinicalTrials.gov (NCT00977288) A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
|
| 14 |
ClinicalTrials.gov (NCT01635946) Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin
|
| 15 |
ClinicalTrials.gov (NCT00631189) Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
|
| 16 |
ClinicalTrials.gov (NCT00491400) Effect of a Fibrate and a Statin on Endothelial Dysfunction
|
| 17 |
ClinicalTrials.gov (NCT01059864) Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550
|
| 18 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 19 |
ClinicalTrials.gov (NCT03460808) The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
|
| 20 |
ClinicalTrials.gov (NCT02080455) Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.
|
| 21 |
ClinicalTrials.gov (NCT01842256) Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
|
| 22 |
ClinicalTrials.gov (NCT02093390) A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects
|
| 23 |
ClinicalTrials.gov (NCT02587416) Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
|
| 24 |
ClinicalTrials.gov (NCT05342974) Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
|
| 25 |
ClinicalTrials.gov (NCT01980823) Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
|
| 26 |
ClinicalTrials.gov (NCT02579356) To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
|
| 27 |
ClinicalTrials.gov (NCT00211939) CARE-2 (Calcium Acetate [PhosLo]/Sevelamer[Renagel] Evaluation Study 2) for Heart Calcification in Dialysis Patients
|
| 28 |
ClinicalTrials.gov (NCT01442428) Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
|
| 29 |
ClinicalTrials.gov (NCT00276484) To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
|
| 30 |
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia. Am Heart J. 2010 Oct;160(4):759-66.
|
| 31 |
ClinicalTrials.gov (NCT00681525) A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
|
| 32 |
ClinicalTrials.gov (NCT00411190) Study To Determine The Effects Of Doses Of Relacatib On The Metabolism Of Acetaminophen, Ibuprofen And Atorvastatin
|
| 33 |
ClinicalTrials.gov (NCT05681273) Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
|
| 34 |
ClinicalTrials.gov (NCT01518231) Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
|
| 35 |
ClinicalTrials.gov (NCT04608344) Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants
|
| 36 |
ClinicalTrials.gov (NCT02243098) Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects
|
| 37 |
ClinicalTrials.gov (NCT02518516) High Potency Statins and Acute Kidney Injury
|
| 38 |
ClinicalTrials.gov (NCT02518503) High Potency Statins and the Risk of Diabetes
|
| 39 |
ClinicalTrials.gov (NCT00166530) EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
|
| 40 |
ClinicalTrials.gov (NCT04824911) Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
|
| 41 |
ClinicalTrials.gov (NCT03110848) Effects of Atorvastatin in Graves' Orbitopathy (GO)
|
| 42 |
ClinicalTrials.gov (NCT05250596) COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS)
|
| 43 |
ClinicalTrials.gov (NCT05792540) Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
|
| 44 |
ClinicalTrials.gov (NCT01863225) Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
|
| 45 |
ClinicalTrials.gov (NCT03830164) Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer
|
| 46 |
ClinicalTrials.gov (NCT05567068) Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
|
| 47 |
ClinicalTrials.gov (NCT02081638) Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
|
| 48 |
ClinicalTrials.gov (NCT05870007) Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
|
| 49 |
ClinicalTrials.gov (NCT02029573) Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
|
| 50 |
ClinicalTrials.gov (NCT02659397) A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
|
| 51 |
ClinicalTrials.gov (NCT01491958) Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
|
| 52 |
ClinicalTrials.gov (NCT02633956) Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
|
| 53 |
ClinicalTrials.gov (NCT02586155) Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
|
| 54 |
ClinicalTrials.gov (NCT02260648) A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia
|
| 55 |
ClinicalTrials.gov (NCT03819101) Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
|
| 56 |
ClinicalTrials.gov (NCT01477853) A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211). U.S. National Institutes of Health.
|
| 57 |
ClinicalTrials.gov (NCT03066466) Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
|
| 58 |
ClinicalTrials.gov (NCT00664469) INdians Followed for INtensive Lipid Lowering Treatment and Its safetY
|
| 59 |
ClinicalTrials.gov (NCT02577042) Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen
|
| 60 |
ClinicalTrials.gov (NCT06139952) Ameliorating Contrast Induced Nephropathy After Coronary Angiography
|
| 61 |
ClinicalTrials.gov (NCT02910778) The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
|
|
|
|
|
|
|
